Published in Am J Cardiol on May 01, 1988
Left ventricular function during balloon dilatation of the aortic valve in elderly patients: a blind study of echocardiograms. Br Heart J (1990) 0.75
[Anesthesia with transfemoral and transapical aortic valve implantation. Periinterventional management and hemodynamic observations]. Herz (2009) 0.75
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol (2000) 3.28
Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase. Biochem J (1980) 2.88
Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J (1980) 2.79
The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem J (1975) 2.72
Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem (1983) 2.63
Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem (1997) 2.43
Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol (1983) 2.10
The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose. Eur J Biochem (1974) 2.10
Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes. Proc Natl Acad Sci U S A (1976) 2.04
Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A (1981) 1.91
The lipid phosphatase SHIP2 controls insulin sensitivity. Nature (2001) 1.90
Control of gluconeogenesis and of enzymes of glycogen metabolism in isolated rat hepatocytes. A parallel study of the effect of phenylephrine and of glucagon. Biochem J (1978) 1.81
Phosphorylation of glucose in isolated rat hepatocytes. Sigmoidal kinetics explained by the activity of glucokinase alone. Biochem J (1978) 1.70
Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liver in vivo. Biochem J (1980) 1.69
Swelling of rat hepatocytes stimulates glycogen synthesis. J Biol Chem (1990) 1.68
Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol (1996) 1.64
Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J (1983) 1.64
Hormonal and ionic control of the glycogenolytic cascade in rat liver. Biochem J (1977) 1.64
The role of futile cycles in the regulation of carbohydrate metabolism in the liver. Adv Enzymol Relat Areas Mol Biol (1981) 1.61
Regulation in vitro and in vivo of adenosine 3':5'-monophosphate-dependent inactivation of rat-liver pyruvate kinase type L. Eur J Biochem (1977) 1.57
Regulation of fructose-2,6-bisphosphate content in rat hepatocytes, perfused hearts, and perfused hindlimbs. J Biol Chem (1982) 1.52
Vasospasm after subarachnoid hemorrhage: diagnosis with MR angiography. AJNR Am J Neuroradiol (2000) 1.49
Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J (1984) 1.49
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia (2011) 1.48
Angiographic evaluation of vasomotor properties of internal mammary arteries before and after coronary artery bypass grafting in men. Am J Cardiol (1990) 1.39
Endovascular repair of iliac aneurysms following aortoiliac surgery. Eur J Vasc Endovasc Surg (1999) 1.38
Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett (2001) 1.37
AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol (2003) 1.33
AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia (2003) 1.30
Signaling pathway involved in the activation of heart 6-phosphofructo-2-kinase by insulin. J Biol Chem (1996) 1.28
Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J (1989) 1.25
Fructose 2,6-bisphosphate. Hormonal regulation and mechanism of its formation in liver. J Biol Chem (1981) 1.24
Activation of rat heart phosphofructokinase-2 by insulin in vivo. FEBS Lett (1984) 1.23
On the use of (3H, 14C)labelled glucose in the study of the so-called "futile cycles" in liver and muscle. Biochem Biophys Res Commun (1974) 1.22
Comparison of purified bovine heart and rat liver 6-phosphofructo-2-kinase. Evidence for distinct isoenzymes. Biochem J (1985) 1.17
Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J (1982) 1.16
Mechanisms of control of heart glycolysis. Eur J Biochem (1998) 1.15
Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem J (1992) 1.14
Comparison of the effects of various amino acids on glycogen synthesis, lipogenesis and ketogenesis in isolated rat hepatocytes. Biochem J (1991) 1.14
Stimulation of glycogen synthesis and lipogenesis by glutamine in isolated rat hepatocytes. Biochem J (1987) 1.14
Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther (1994) 1.13
Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine. Circulation (1980) 1.12
Mechanism of activation of liver glycogen synthase by swelling. J Biol Chem (1992) 1.12
Characterization of distinct mRNAs coding for putative isozymes of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Eur J Biochem (1989) 1.11
Phorbol 12-myristate 13-acetate and insulin increase the concentration of fructose 2,6-bisphosphate and stimulate glycolysis in chicken embryo fibroblasts. Proc Natl Acad Sci U S A (1985) 1.09
Complete nucleotide sequence coding for rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase derived from a cDNA clone. FEBS Lett (1987) 1.09
Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. Biochem J (1973) 1.08
5' flanking sequence and structure of a gene encoding rat 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Proc Natl Acad Sci U S A (1989) 1.07
Utile and futile cycles in the liver. Biochem Biophys Res Commun (1974) 1.06
Role of fructose 2,6-bisphosphate in the stimulation of glycolysis by anoxia in isolated hepatocytes. Biochem J (1982) 1.05
Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail (2000) 1.04
Hepatocyte swelling increases inositol 1,4,5-trisphosphate, calcium and cyclic AMP concentration but antagonizes phosphorylase activation by Ca2(+)-dependent hormones. FEBS Lett (1991) 1.04
Regulation of fructose 2,6-bisphosphate concentration in white adipose tissue. Biochem J (1985) 1.03
Fructose 2,6-bisphosphate in rat skeletal muscle during contraction. Biochem J (1984) 1.02
Stimulation of glycolysis and accumulation of a stimulator of phosphofructokinase in hepatocytes incubated with vasopressin. Biochem J (1981) 1.02
Mammalian 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a bifunctional enzyme that controls glycolysis. Prog Nucleic Acid Res Mol Biol (1993) 1.02
Protein kinase signaling pathway triggered by cell swelling and involved in the activation of glycogen synthase and acetyl-CoA carboxylase in isolated rat hepatocytes. J Biol Chem (1996) 1.01
Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol (2000) 1.00
Saccular aneurysm of the external jugular vein, an unusual cause of neck swelling. J Belge Radiol (1997) 1.00
Force-velocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility. Am J Cardiol (1983) 0.99
Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem J (1986) 0.99
Bilateral mammary grafting. Clinical, functional and angiographic assessment in 400 consecutive patients. Eur J Cardiothorac Surg (1993) 0.99
Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart. J Clin Invest (1998) 0.98
Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase. Biochem J (2000) 0.98
Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study. Biochem J (1985) 0.97
Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. J Biol Chem (1999) 0.97
Effects of coronary occlusion on early ventricular diastolic events in conscious dogs. Am J Physiol (1979) 0.96
Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem. J Cardiovasc Pharmacol (1992) 0.96
No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res (2001) 0.95
Effects of glucose on phosphorylase and glycogen synthase in hepatocytes from diabetic rats. Biochem J (1983) 0.94
Effect of glutamine on fructose 2,6-bisphosphate and on glucose metabolism in HeLa cells and in chick-embryo fibroblasts. Biochem J (1985) 0.94
Molecular forms of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase expressed in rat skeletal muscle. J Biol Chem (1992) 0.94
Glycogen storage diseases. Biochimie (1972) 0.94
Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure. Circulation (1980) 0.94
Extracellular metabolites in suspensions of isolated hepatocytes. Biochem J (1987) 0.93
Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res (1997) 0.93
Protection of rats against hypoglycin and pent-4-enoate toxicity by pretreatment with clofibrate [proceedings]. Biochem Soc Trans (1979) 0.92
Antagonistic effects of leucine and glutamine on the mTOR pathway in myogenic C2C12 cells. Amino Acids (2007) 0.92
Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results. Eur J Vasc Endovasc Surg (2000) 0.91
Carotid stenting for impending carotid blowout: suitable supportive care for head and neck cancer patients? Palliat Med (2005) 0.91
Starvation or diabetes decreases the content but not the mRNA of 6-phosphofructo-2-kinase in rat liver. FEBS Lett (1988) 0.91
Role of fructose 2,6-bisphosphate in the control of heart glycolysis. J Biol Chem (1993) 0.90
Rat muscle 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Study of the kinase domain by site-directed mutagenesis. J Biol Chem (1993) 0.89
Fructose 2,6-bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells. Cancer Res (1985) 0.89
Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness. Circulation (1984) 0.89
Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am Coll Cardiol (1989) 0.89
Swelling of rat hepatocytes activates acetyl-CoA carboxylase in parallel to glycogen synthase. Biochem J (1991) 0.88
Phosphorylation of purified bovine heart and rat liver 6-phosphofructo-2-kinase by protein kinase C and comparison of the fructose-2,6-bisphosphatase activity of the two enzymes. Biochem J (1986) 0.88
Activation of hepatic acetyl-CoA carboxylase by glutamate and Mg2+ is mediated by protein phosphatase-2A. Biochem J (1996) 0.88
Mechanism of activation of liver acetyl-CoA carboxylase by cell swelling. Eur J Biochem (1993) 0.88
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol (1994) 0.88
The ATP-binding site in the 2-kinase domain of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Study of the role of Lys-54 and Thr-55 by site-directed mutagenesis. J Biol Chem (1996) 0.87
Rat hepatoma (HTC) cell 6-phosphofructo-2-kinase differs from that in liver and can be separated from fructose-2,6-bisphosphatase. Eur J Biochem (1988) 0.87
Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol (1991) 0.87
Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol. J Cardiovasc Pharmacol (1993) 0.87
Diagnosis of intracranial aneurysms: accuracy of MR angiography at 0.5 T. AJNR Am J Neuroradiol (1998) 0.87
Cell shrinkage follows, rather than mediates, the short-term effects of glucagon on carbohydrate metabolism. Biochem J (1992) 0.87